How is the Context Therapeutics Inc today?

The Context Therapeutics Inc today is trading in the down by -3.57% at 0.81.

What is Context Therapeutics Inc Annual Net Profit?

Context Therapeutics Inc Annual Net Profit fell 11.52% in the last year to $26.73 M. Its sector's average net profit growth for the last fiscal year was -32.31%.

What is Context Therapeutics Inc Price to Earning Ratio?

Context Therapeutics Inc Price to Earning Ratio is -2.72, which is negative.

What is Context Therapeutics Inc Stock Price?

Context Therapeutics Inc Stock Price fell 56.22% and underperformed its sector by 60.57% in the past year.

What is Context Therapeutics Inc Quarterly Net profit?

Context Therapeutics Inc Quarterly Net profit rose 50.62% YoY to $3.34 M. Its sector's average net profit growth YoY for the quarter was -29.01%.

What is Context Therapeutics Inc Debt to Equity Ratio?

Context Therapeutics Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Context Therapeutics Inc Return on Equity(ROE)?

Context Therapeutics Inc Return on Equity(ROE) for the last financial year was -49.89%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Context Therapeutics Inc Mutual Fund Holding?

Context Therapeutics Inc Mutual Fund Holding decreased by 1.58% in the last quarter to 13.52.

What is Context Therapeutics Inc Institutional Holding?

Context Therapeutics Inc Institutional Holding remained the same in the last quarter at 82.47%.

Context Therapeutics Inc XNAS: CNTX

Context Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Context Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Context Therapeutics Inc
Rating: 1.12158325
Author: Trendlyne DVM scores

about

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...

0.81 -0.03 (-3.57%)

70.55% Fall from 52W High

81,229 XNAS Volume

XNAS 06 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

12.3 / 100

Technically Bearish

32.5 / 100

No estimates available

Context Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Context Therapeutics Inc FAQ

How is Context Therapeutics Inc today?

Context Therapeutics Inc today is trading in the red, and is down by -3.57% at 0.81.

How has Context Therapeutics Inc performed historically?

Context Therapeutics Inc is currently trading down -3.57% on an intraday basis. In the past week the stock fell -13.83%. stock has been down -15.62% in the past quarter and fell -56.22% in the past year. You can view this in the overview section.